ORBIMED ADVISORS LLC Q3 2024 Filing
Filed November 14, 2024
Portfolio Value
$5.5B
Holdings
113
Report Date
Q3 2024
Filing Type
13F-HR
All Holdings (113 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | TRAWTRAWS PHARMA INC | 605,531 | $3.6B | 64.70% | |
| 102 | MISTMILESTONE PHARMACEUTICALS IN | 2,000,000 | $3.0B | 55.24% | |
| 103 | SAVACASSAVA SCIENCES INC | 95,000 | $2.8B | 50.80% | Put |
| 104 | CMMBCHEMOMAB THERAPEUTICS LTD | 1,741,273 | $2.7B | 49.67% | |
| 105 | TILINSTIL BIO INC | 33,700 | $2.3B | 41.22% | |
| 106 | PHGEBIOMX INC | 1,787,767 | $1.8B | 33.13% | |
| 107 | GONGERON CORP | 400,000 | $1.8B | 33.00% | Call |
| 108 | IVVDINVIVYD INC | 1,728,300 | $1.8B | 32.03% | |
| 109 | —TURNSTONE BIOLOGICS CORP | 3,099,265 | $1.7B | 31.37% | |
| 110 | NXTCNEXTCURE INC | 1,141,200 | $1.6B | 28.41% | |
| 111 | VIGLVIGIL NEUROSCIENCE INC | 448,891 | $1.5B | 27.73% | |
| 112 | KZRKEZAR LIFE SCIENCES INC | 1,927,000 | $1.5B | 27.07% | |
| 113 | —ELEVATION ONCOLOGY INC | 941,275 | $564.7M | 10.26% | |
| 114 | XERSXERIS BIOPHARMA HOLDINGS INC | 80,420 | $229.2M | 4.16% |
PreviousPage 2 of 2